Key result
Smoking bans are linked to a ~4% reduction in acute myocardial infarction admissions.
Answers are grounded in this paper and cite their sources.
We update an earlier review of smoking bans and heart disease, restricting attention to admissions for acute myocardial infarction. Forty-five studies are considered. New features of our update include consideration of non-linear trends in the underlying rate, a modified trend adjustment method where there are multiple time periods post-ban, comparison of estimates based on changes in rates and numbers of cases, and comparison of effect estimates according to post-ban changes in smoking restrictiveness. Using a consistent approach to derive ban effect estimates, taking account of linear time trends and control data, the reduction in risk following a ban was estimated as 4.2% (95% confidence interval 1.8-6.5%). Excluding regional estimates where national estimates are available, and studies where trend adjustment was not possible, the estimate reduced to 2.6% (1.1-4.0%). Estimates were little affected by non-linear trend adjustment, where possible, or by basing estimates on changes in rates. Ban effect estimates tended to be greater in smaller studies, and studies with greater post-ban changes in smoking restrictiveness. Though the findings suggest a true effect of smoking bans, uncertainties remain, due to the weakness of much of the evidence, the small estimated effect, and various possibilities of bias.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2014) conducted a review in Acute myocardial infarction. Smoking bans vs. Pre-ban period or control data was evaluated on Admissions for acute myocardial infarction (Risk reduction 4.2%, 95% CI 1.8-6.5%). Smoking bans were associated with a 4.2% reduction in risk of acute myocardial infarction admissions, decreasing to 2.6% after excluding regional and unadjusted data.
Synapse has enriched 10 related papers. Consider them for comparative context: